{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:21:53Z","timestamp":1720484513098},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,8]]},"DOI":"10.7759\/cureus.64067","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T10:59:07Z","timestamp":1720436347000},"source":"Crossref","is-referenced-by-count":0,"title":["The Role of Tenascin-C in the Physiopathology of Familial Mediterranean Fever"],"prefix":"10.7759","author":[{"given":"Emin","family":"Guluzade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berna","family":"G\u00fczel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demet","family":"Yalcin Kehribar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Okuyucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"\u00d6zgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahattin","family":"Avc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.045","article-title":"Diagnostic criteria of familial Mediterranean fever","volume":"13","author":"Berkun Y","year":"2014","unstructured":"Berkun Y, Eisenstein EM. Diagnostic criteria of familial Mediterranean fever. Autoimmun Rev. 2014, 13:388-90. 10.1016\/j.autrev.2014.01.045","journal-title":"Autoimmun Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.026963","article-title":"E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever","volume":"64","author":"Topaloglu R","year":"2005","unstructured":"Topaloglu R, Ozaltin F, Yilmaz E, Ozen S, Balci B, Besbas N, Bakkaloglu A. E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever. Ann Rheum Dis. 2005, 64:750-2. 10.1136\/ard.2004.026963","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2102-13","article-title":"Mean platelet volume in familial Mediterranean fever related AA amyloidosis and comparison with common primary glomerular diseases","volume":"51","author":"Y\u0131ld\u0131r\u0131m T","year":"2021","unstructured":"Y\u0131ld\u0131r\u0131m T, K\u00fctahya B, \u0130\u015f F, et al.. Mean platelet volume in familial Mediterranean fever related AA amyloidosis and comparison with common primary glomerular diseases. Turk J Med Sci. 2021, 51:2364-8. 10.3906\/sag-2102-13","journal-title":"Turk J Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04852-0","article-title":"Contribution of Arab countries to familial Mediterranean fever research: a PubMed-based bibliometric analysis","volume":"42","author":"Masri DE","year":"2022","unstructured":"Masri DE, Alsaayed B, Masri JE, Zreika B, Chanbour H, Salameh P. Contribution of Arab countries to familial Mediterranean fever research: a PubMed-based bibliometric analysis. Rheumatol Int. 2022, 42:95-100. 10.1007\/s00296-021-04852-0","journal-title":"Rheumatol Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.07.019","article-title":"Familial Mediterranean fever: new phenotypes","volume":"12","author":"Soriano A","year":"2012","unstructured":"Soriano A, Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev. 2012, 12:31-7. 10.1016\/j.autrev.2012.07.019","journal-title":"Autoimmun Rev"},{"key":"ref6","article-title":"Weighting the potential of using tenascin C in diagnosis and therapy of atherosclerosis","volume":"42","author":"Pawitan JA","year":"2010","unstructured":"Pawitan JA. Weighting the potential of using tenascin C in diagnosis and therapy of atherosclerosis. Acta Med Indones. 2010, 42:104-7.","journal-title":"Acta Med Indones"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4161\/19336918.2014.994901","article-title":"Tenascins in fibrotic disorders-from bench to bedside","volume":"9","author":"Kasprzycka M","year":"2015","unstructured":"Kasprzycka M, Hammarstr\u00f6m C, Haraldsen G. Tenascins in fibrotic disorders-from bench to bedside. Cell Adh Migr. 2015, 9:83-9. 10.4161\/19336918.2014.994901","journal-title":"Cell Adh Migr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103512","article-title":"Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases","volume":"23","author":"Ondrej\u010d\u00e1kov\u00e1 L","year":"2024","unstructured":"Ondrej\u010d\u00e1kov\u00e1 L, Gregov\u00e1 M, Bubov\u00e1 K, \u0160enolt L, Pavelka K. Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases. Autoimmun Rev. 2024, 23:103512. 10.1016\/j.autrev.2023.103512","journal-title":"Autoimmun Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2022.03.019","article-title":"Tenascin-C in fibrosis in multiple organs: translational implications","volume":"128","author":"Bhattacharyya S","year":"2022","unstructured":"Bhattacharyya S, Midwood KS, Varga J. Tenascin-C in fibrosis in multiple organs: translational implications. Semin Cell Dev Biol. 2022, 128:130-6. 10.1016\/j.semcdb.2022.03.019","journal-title":"Semin Cell Dev Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000481911","article-title":"Tenascin-X, congenital adrenal hyperplasia, and the CAH-X syndrome","volume":"89","author":"Miller WL","year":"2018","unstructured":"Miller WL, Merke DP. Tenascin-X, congenital adrenal hyperplasia, and the CAH-X syndrome. Horm Res Paediatr. 2018, 89:352-61. 10.1159\/000481911","journal-title":"Horm Res Paediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010238","article-title":"The functional role of extracellular matrix proteins in cancer","volume":"14","author":"Popova NV","year":"2022","unstructured":"Popova NV, J\u00fccker M. The functional role of extracellular matrix proteins in cancer. Cancers (Basel). 2022, 14:238. 10.3390\/cancers14010238","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.577015","article-title":"Tenascin-C in osteoarthritis and rheumatoid arthritis","volume":"11","author":"Hasegawa M","year":"2020","unstructured":"Hasegawa M, Yoshida T, Sudo A. Tenascin-C in osteoarthritis and rheumatoid arthritis. Front Immunol. 2020, 11:577015. 10.3389\/fimmu.2020.577015","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.934414","article-title":"Elevated tenascin-C serum levels in patients with axial spondyloarthritis","volume":"69","author":"Bubov\u00e1 K","year":"2020","unstructured":"Bubov\u00e1 K, Prajzlerov\u00e1 K, Hulejov\u00e1 H, et al.. Elevated tenascin-C serum levels in patients with axial spondyloarthritis. Physiol Res. 2020, 69:653-60. 10.33549\/physiolres.934414","journal-title":"Physiol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401023","article-title":"Criteria for the diagnosis of familial Mediterranean fever","volume":"40","author":"Livneh A","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D, et al.. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997, 40:1879-85. 10.1002\/art.1780401023","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/19336918.2015.1008333","article-title":"Transcriptional regulation of tenascin genes","volume":"9","author":"Chiovaro F","year":"2015","unstructured":"Chiovaro F, Chiquet-Ehrismann R, Chiquet M. Transcriptional regulation of tenascin genes. Cell Adh Migr. 2015, 9:34-47. 10.1080\/19336918.2015.1008333","journal-title":"Cell Adh Migr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.10.772","article-title":"Influence of interleukin 1 beta on tenascin distribution in human normal and osteoarthritic cartilage: a quantitative immunohistochemical study","volume":"55","author":"Chevalier X","year":"1996","unstructured":"Chevalier X, Claudepierre P, Groult N, Godeau GJ. Influence of interleukin 1 beta on tenascin distribution in human normal and osteoarthritic cartilage: a quantitative immunohistochemical study. Ann Rheum Dis. 1996, 55:772-5. 10.1136\/ard.55.10.772","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215063","article-title":"Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis","volume":"79","author":"Cutolo M","year":"2020","unstructured":"Cutolo M, Soldano S, Paolino S. Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis. Ann Rheum Dis. 2020, 79:e42. 10.1136\/annrheumdis-2019-215063","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0862-4","article-title":"Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study","volume":"17","author":"Z\u00e1vada J","year":"2015","unstructured":"Z\u00e1vada J, Uher M, Svobodov\u00e1 R, et al.. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study. Arthritis Res Ther. 2015, 17:341. 10.1186\/s13075-015-0862-4","journal-title":"Arthritis Res Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/path.2099","article-title":"Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice","volume":"211","author":"El-Karef A","year":"2007","unstructured":"El-Karef A, Yoshida T, Gabazza EC, Nishioka T, Inada H, Sakakura T, Imanaka-Yoshida K. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol. 2007, 211:86-94. 10.1002\/path.2099","journal-title":"J Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/09168451.2016.1165600","article-title":"Tenascin-C promotes migration of hepatic stellate cells and production of type I collagen","volume":"80","author":"Ma JC","year":"2016","unstructured":"Ma JC, Huang X, Shen YW, Zheng C, Su QH, Xu JK, Zhao J. Tenascin-C promotes migration of hepatic stellate cells and production of type I collagen. Biosci Biotechnol Biochem. 2016, 80:1470-7. 10.1080\/09168451.2016.1165600","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/art.30647","article-title":"Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3","volume":"64","author":"Brissett M","year":"2012","unstructured":"Brissett M, Veraldi KL, Pilewski JM, Medsger TA Jr, Feghali-Bostwick CA. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Arthritis Rheum. 2012, 64:272-80. 10.1002\/art.30647","journal-title":"Arthritis Rheum"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11703","article-title":"Tenascin-C drives persistence of organ fibrosis","volume":"7","author":"Bhattacharyya S","year":"2016","unstructured":"Bhattacharyya S, Wang W, Morales-Nebreda L, et al.. Tenascin-C drives persistence of organ fibrosis. Nat Commun. 2016, 7:11703. 10.1038\/ncomms11703","journal-title":"Nat Commun"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.46497\/Arch Rheumatol.2024.10163","article-title":"An investigation of the relationship between Beh\u00e7et\u2019s disease and tenascin-C","volume":"39","author":"Kaplan H","year":"2024","unstructured":"Kaplan H, Kehribar DY, Okuyucu M, Ozgen M. An investigation of the relationship between Beh\u00e7et\u2019s disease and tenascin-C. Arch Rheumatol. 2024, 39:107-14. 10.46497\/Arch Rheumatol.2024.10163","journal-title":"Arch Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/262767-the-role-of-tenascin-c-in-the-physiopathology-of-familial-mediterranean-fever","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T10:59:10Z","timestamp":1720436350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/262767-the-role-of-tenascin-c-in-the-physiopathology-of-familial-mediterranean-fever"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.64067","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,8]]}}}